Literature DB >> 16192810

Adjuvant radiotherapy is associated with increased sexual dysfunction in male patients undergoing resection for rectal cancer: a predictive model.

Alexander G Heriot1, Paris P Tekkis, Victor W Fazio, Paul Neary, Ian C Lavery.   

Abstract

OBJECTIVES: The objectives of this study were to evaluate the effect of radiotherapy (RT) on sexual function in patients undergoing oncologic resection for rectal cancer, and to develop a mathematical model for quantifying the risk of sexual dysfunction through time for this group of patients.
METHODS: Data were prospectively collected on patients undergoing proctosigmoidectomy (group 1: n = 101) or adjuvant radiotherapy (40-50 Gy) and resection (group 2: n = 100) for rectal cancer at a tertiary referral center between December 1998 and July 2004. Study end points were recorded at 7 time intervals (preoperatively, 4 months, 8 months, 1 year, 2 years, 3 years, and 4 years after surgery) and included: 1) ability to have an erection, 2) maintain an erection, 3) attain orgasm, 4) dry orgasm, and 5) whether they were sexually active. Multilevel logistic regression analysis for repeated measures was used to identify factors associated with the sexual dysfunction. A predictive model was developed and internally validated by comparing observed and model-predicted outcomes.
RESULTS: Radiotherapy had an adverse effect on the ability to get an erection, maintain an erection, attain orgasm, and being sexually active in comparison with patients undergoing surgery alone (7.4%, 12.6%, 16.2%, and 13.7% reduction 8 months after surgery respectively; P < 0.05). The effect of sexual dysfunction deteriorated with age (odds ratio for erectile function, 0.40 per 10-year increase in age; 95% confidence interval, 0.29-0.49; P < 0.001). A significant variability in sexual function was present among the 7 time points with a maximal deterioration occurring at 8 months after surgery with subsequent slow but not complete recovery (P < 0.001). The predictive model showed adequate discrimination on 4 of the 5 domains of sexual dysfunction (area under the receiver operating characteristic curve >0.70).
CONCLUSIONS: Radiotherapy has an adverse effect on sexual function, the effect being maximal at 8 months after surgery. The risk of sexual dysfunction can be quantified preoperatively using the proposed index and can assist patients in making better informed choices on the type of treatment they receive.

Entities:  

Mesh:

Year:  2005        PMID: 16192810      PMCID: PMC1402349          DOI: 10.1097/01.sla.0000183608.24549.68

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  29 in total

Review 1.  Is radiotherapy for rectal cancer indicated if surgery is optimized?

Authors:  D P Edwards; N J Mortensen
Journal:  Eur J Surg Oncol       Date:  2001-08       Impact factor: 4.424

2.  Assessment of sexual and voiding function after total mesorectal excision with pelvic autonomic nerve preservation in males with rectal cancer.

Authors:  Nam Kyu Kim; Tae Wan Aahn; Jea Kun Park; Kang Young Lee; Woong Hee Lee; Seung Kook Sohn; Jin Sik Min
Journal:  Dis Colon Rectum       Date:  2002-09       Impact factor: 4.585

3.  Clinical effects of preoperative radiation therapy on anorectal function after proctectomy and colonic J-pouch-anal anastomosis.

Authors:  Nidal Dehni; Deborah A McNamara; Rodulfo D Schlegel; Marguerite Guiguet; Emmanuel Tiret; Rolland Parc
Journal:  Dis Colon Rectum       Date:  2002-12       Impact factor: 4.585

4.  Adjuvant radiotherapy for rectal cancer: a systematic overview of 8,507 patients from 22 randomised trials.

Authors: 
Journal:  Lancet       Date:  2001-10-20       Impact factor: 79.321

5.  Total mesorectal excision preserves male genital function compared with conventional rectal cancer surgery.

Authors:  C A Maurer; K Z'Graggen; P Renzulli; M K Schilling; P Netzer; M W Büchler
Journal:  Br J Surg       Date:  2001-11       Impact factor: 6.939

6.  Improving the preservation of erectile function after external beam radiation therapy for prostate cancer.

Authors:  M al-Abany; G Steineck; A K Agren Cronqvist; A R Helgason
Journal:  Radiother Oncol       Date:  2000-11       Impact factor: 6.280

7.  Urologic and sexual morbidity following multimodality treatment for locally advanced primary and locally recurrent rectal cancer.

Authors:  G H Mannaerts; M P Schijven; A Hendrikx; H Martijn; H J Rutten; T Wiggers
Journal:  Eur J Surg Oncol       Date:  2001-04       Impact factor: 4.424

8.  Bladder and sexual dysfunction after mesorectal excision for rectal cancer.

Authors:  A Nesbakken; K Nygaard; T Bull-Njaa; E Carlsen; L M Eri
Journal:  Br J Surg       Date:  2000-02       Impact factor: 6.939

Review 9.  Management and imaging of low rectal carcinoma.

Authors:  Gisella Salerno; Ian Daniels; R J Heald; Gina Brown; B J Moran
Journal:  Surg Oncol       Date:  2004 Aug-Nov       Impact factor: 3.279

10.  Effects of preoperative radiotherapy for primary resectable rectal adenocarcinoma on male sexual and urinary function.

Authors:  Catherine Bonnel; Yann R Parc; Marc Pocard; Nidal Dehni; Scott Caplin; Rolland Parc; Emmanuel Tiret
Journal:  Dis Colon Rectum       Date:  2002-07       Impact factor: 4.585

View more
  20 in total

1.  Adjuvant radiotherapy following total mesorectal excision for stage IIA rectal cancer: is it beneficial?

Authors:  Jin Soo Kim; Nam Kyu Kim; Byung Soh Min; Hyuk Hur; Joong Bae Ahn; Ki Chang Keum
Journal:  Int J Colorectal Dis       Date:  2010-06-11       Impact factor: 2.571

2.  Local treatment for rectal cancer.

Authors:  Daniel P Geisler
Journal:  Clin Colon Rectal Surg       Date:  2007-08

Review 3.  Function preservation in rectal cancer surgery.

Authors:  Yoshihiro Moriya
Journal:  Int J Clin Oncol       Date:  2006-10       Impact factor: 3.402

Review 4.  Sexual dysfunction following rectal cancer surgery.

Authors:  V Celentano; R Cohen; J Warusavitarne; O Faiz; M Chand
Journal:  Int J Colorectal Dis       Date:  2017-05-11       Impact factor: 2.571

5.  Prospective study of sexual dysfunction in men with rectal cancer: feasibility and results of nerve sparing surgery.

Authors:  Valerio Celentano; Giovanni Fabbrocile; Gaetano Luglio; Giovanni Antonelli; Rachele Tarquini; Luigi Bucci
Journal:  Int J Colorectal Dis       Date:  2010-06-26       Impact factor: 2.571

6.  Men's experience with sexual dysfunction post-rectal cancer treatment: a qualitative study.

Authors:  Melinda Ball; Christian J Nelson; Elyse Shuk; Tatiana D Starr; Larissa Temple; Lina Jandorf; Leslie Schover; John P Mulhall; Heidi Woo; Sabrina Jennings; Katherine DuHamel
Journal:  J Cancer Educ       Date:  2013-09       Impact factor: 2.037

7.  miRNA expressions in rectal cancer as predictors of response to neoadjuvant chemoradiation therapy.

Authors:  Elrasheid A H Kheirelseid; Nicola Miller; Kah Hoong Chang; Catherine Curran; Emer Hennessey; Margaret Sheehan; John Newell; Christophe Lemetre; Graham Balls; Michael J Kerin
Journal:  Int J Colorectal Dis       Date:  2012-08-18       Impact factor: 2.571

8.  Outcome of patients with clinical stage II or III rectal cancer treated without adjuvant radiotherapy.

Authors:  Shin Fujita; Seiichiro Yamamoto; Takayuki Akasu; Yoshihiro Moriya
Journal:  Int J Colorectal Dis       Date:  2008-07-02       Impact factor: 2.571

Review 9.  An update on microRNAs as colorectal cancer biomarkers: where are we and what's next?

Authors:  Yoshinaga Okugawa; Yuji Toiyama; Ajay Goel
Journal:  Expert Rev Mol Diagn       Date:  2014-08-28       Impact factor: 5.225

10.  Colorectal anastomosis using a novel double-stapling technique for lower rectal carcinoma.

Authors:  Harunobu Sato; Koutarou Maeda; Tsunekazu Hanai; Hiroyuki Aoyama
Journal:  Int J Colorectal Dis       Date:  2007-02-15       Impact factor: 2.571

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.